Fineline Cube

Follow:
14778 Articles
Jiangsu Kanion Pharmaceutical Secures NMPA Approvals for KYHY2302 and KYHY2303
CompanyDrug

Jiangsu Kanion Pharmaceutical Secures NMPA Approvals for KYHY2302 and KYHY2303

NHSA Issues Guidelines to Suspend Direct Online Listing of In-Shortage Drugs
Policy / Regulatory

NHSA Issues Guidelines to Suspend Direct Online Listing of In-Shortage Drugs

BeiGene's Tevimbra Receives EC Approval for First-Line ESCC and G/GEJ Adenocarcinoma Treatments
CompanyDrug

BeiGene’s Tevimbra Receives EC Approval for First-Line ESCC and G/GEJ Adenocarcinoma Treatments

Fosun Pharmaceutical's Daxxify Receives NMPA Approval for Cervical Muscle Tone Disorders
CompanyDrug

Fosun Pharmaceutical’s Daxxify Receives NMPA Approval for Cervical Muscle Tone Disorders

Phil Rivers Technology Secures IND Approval for PR00012 from NMPA's CDE
CompanyDrug

Phil Rivers Technology Secures IND Approval for PR00012 from NMPA’s CDE

Hansoh Pharmaceutical's Ameile Receives NMPA Review for Fifth Indication in NSCLC Treatment
CompanyDrug

Hansoh Pharmaceutical’s Ameile Receives NMPA Review for Fifth Indication in NSCLC Treatment

China Medical System Holdings Gets NMPA Approval to Test Obesity Treatment CMS-D005
CompanyDrug

China Medical System Holdings Gets NMPA Approval to Test Obesity Treatment CMS-D005

Genesis RMN Robotic Magnetic Navigation System Approved by China's NMPA
CompanyMedical Device

Genesis RMN Robotic Magnetic Navigation System Approved by China’s NMPA

GSK plc Receives EC Approval for Single-Vial Menveo Vaccine for Meningococcal Disease
CompanyDrug

GSK plc Receives EC Approval for Single-Vial Menveo Vaccine for Meningococcal Disease

TenNor Therapeutics Partners with Grand Life Sciences for Rifasutenizol Commercialization in China
CompanyDeals

TenNor Therapeutics Partners with Grand Life Sciences for Rifasutenizol Commercialization in China

Immunochina Pharmaceuticals' IM19 CAR-T Therapy Accepted for Review by NMPA
CompanyDrug

Immunochina Pharmaceuticals’ IM19 CAR-T Therapy Accepted for Review by NMPA

Thederma’s TAP-1503 Cream Approved by China’s NMPA for Atopic Dermatitis Treatment
CompanyDrug

Thederma’s TAP-1503 Cream Approved by China’s NMPA for Atopic Dermatitis Treatment